Corrigendum to Mann JFE, Muskiet MHA. Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists. Kidney Int. 2021;99:314-318. . Kidney Int 2021;100:1351-1352.

Read + Share

Amedeo Smart

Independent Medical Education